CCRN practice question 6 of 25

A nurse is caring for a patient with pulmonary fibrosis who is exhibiting shortness of breath, tachypnea, and feels a sense of impending doom. In order to relieve these symptoms, the nurse should anticipate an order for

Full set: 150 questions
Answer options
A: morphine. Correct answer
B: hydromorphone.
C: lorazepam.
D: diazepam.
Correct Answer:
A. morphine.
Explanation

Low-dose intravenous morphine is the first-line pharmacologic agent for relieving the sensation of dyspnea (air hunger), particularly in patients with advanced respiratory disease like pulmonary fibrosis. It acts on central opioid receptors to reduce the perception of breathlessness and also has an anxiolytic effect, which helps alleviate the associated feeling of "impending doom." Its use is supported by extensive evidence for palliative symptom management in this population.

Why Incorrect

B. Hydromorphone is an alternative opioid but morphine is the most studied and typically recommended first-line agent for dyspnea.
C. Lorazepam is a benzodiazepine that primarily treats anxiety but is less effective than opioids for the sensation of dyspnea itself; it is considered second-line.
D. Diazepam, like lorazepam, is a benzodiazepine used for anxiety and is not the primary treatment for the sensation of breathlessness.

References

1. Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., Mahler, D. A., Meek, P. M., & O'Donnell, D. E. (2012). An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine, 185(4), 435–452. https://doi.org/10.1164/rccm.201111-2042ST (Section: "Management of Dyspnea," Subsection: "Opioids," specifically mentions systemic morphine as effective for reducing dyspnea.)

2. Currow, D. C., Abernethy, A. P., & Ko, D. N. (2022). Dyspnea: Etiology, assessment, and treatment. In T.W. Post (Ed.), UpToDate. Retrieved from UpToDate. (This topic review explicitly states, "For patients with dyspnea that is refractory to therapy of the underlying cause, we suggest a trial of opioid therapy (Grade 2B). Morphine is the opioid of choice...")

3. Jennings, A. L., Davies, A. N., Higgins, J. P., Gibbs, J. S., & Broadley, K. E. (2002). A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57(11), 939–944. https://doi.org/10.1136/thorax.57.11.939 (This systematic review concludes that opioids, particularly morphine, are effective in relieving the symptom of dyspnea.)

Scroll to Top